Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for ENvue Medical (FEED) over the last 7 years, with Q3 2025 value amounting to $2.8 million.

  • ENvue Medical's Other Non Operating Income rose 3546250.0% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 2170000.0%. This contributed to the annual value of $31000.0 for FY2024, which is 12792.79% up from last year.
  • Latest data reveals that ENvue Medical reported Other Non Operating Income of $2.8 million as of Q3 2025, which was up 3546250.0% from $211000.0 recorded in Q2 2025.
  • ENvue Medical's 5-year Other Non Operating Income high stood at $2.8 million for Q3 2025, and its period low was -$5.7 million during Q3 2021.
  • Over the past 5 years, ENvue Medical's median Other Non Operating Income value was -$13000.0 (recorded in 2022), while the average stood at -$267600.0.
  • As far as peak fluctuations go, ENvue Medical's Other Non Operating Income plummeted by 3886000.0% in 2021, and later soared by 3546250.0% in 2025.
  • ENvue Medical's Other Non Operating Income (Quarter) stood at -$5.7 million in 2021, then soared by 99.68% to -$18000.0 in 2022, then crashed by 272.22% to -$67000.0 in 2023, then skyrocketed by 67.16% to -$22000.0 in 2024, then soared by 13031.82% to $2.8 million in 2025.
  • Its Other Non Operating Income stands at $2.8 million for Q3 2025, versus $211000.0 for Q2 2025 and -$10000.0 for Q1 2025.